The biological pathways of Alzheimer disease: a review

被引：146

作者：

Calabro, Marco ^{[1
]}

Rinaldi, Carmela ^{[1
]}

Santoro, Giuseppe ^{[1
]}

Crisafulli, Concetta ^{[1
]}

机构：

[1] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy

来源：

AIMS NEUROSCIENCE | 2021年 / 8卷 / 01期

关键词：

Alzheimer disease; biological pathways; immune system; oxidative stress; AMYLOID-BETA-PEPTIDE; GENOME-WIDE ASSOCIATION; BRAIN INSULIN-RESISTANCE; LONG-TERM POTENTIATION; APOLIPOPROTEIN-E; A-BETA; OXIDATIVE STRESS; COGNITIVE IMPAIRMENT; CEREBRAL HYPOPERFUSION; DIAGNOSTIC GUIDELINES;

D O I：

10.3934/Neuroscience.2021005

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Alzheimer disease is a progressive neurodegenerative disorder, mainly affecting older people, which severely impairs patients' quality of life. In the recent years, the number of affected individuals has seen a rapid increase. It is estimated that up to 107 million subjects will be affected by 2050 worldwide. Research in this area has revealed a lot about the biological and environmental underpinnings of Alzheimer, especially its correlation with beta-Amyloid and Tau related mechanics; however, the precise molecular events and biological pathways behind the disease are yet to be discovered. In this review, we focus our attention on the biological mechanics that may lie behind Alzheimer development. In particular, we briefly describe the genetic elements and discuss about specific biological processes potentially associated with the disease.

引用

页码：86 / 132

页数：47

共 424 条

[21] Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease
Ashby, Emma Louise
Kehoe, Patrick G.
[J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (10) : 1229 - 1242
[22] The Aging of Iron Man
Ashraf, Azhaar
Clark, Maryam
So, Po-Wah
[J]. FRONTIERS IN AGING NEUROSCIENCE, 2018, 10
[23] Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic
Aso, Ester
Ferrer, Isidre
[J]. FRONTIERS IN PHARMACOLOGY, 2014, 5
[24] Molecular targets of oxidative stress
Avery, Simon V.
[J]. BIOCHEMICAL JOURNAL, 2011, 434 : 201 - 210
[25] Activated microglia mediate synapse loss and short-term memory deficits in a mouse model of transthyretin-related oculoleptomeningeal amyloidosis
Azevedo, E. P.
Ledo, J. H.
Barbosa, G.
Sobrinho, M.
Diniz, L.
Fonseca, A. C. C.
Gomes, F.
Romao, L.
Lima, F. R. S.
Palhano, F. L.
Ferreira, S. T.
Foguel, D.
[J]. CELL DEATH & DISEASE, 2013, 4 : e789 - e789
[26] Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease
Baker-Nigh, Alaina
Vahedi, Shahrooz
Davis, Elena Goetz
Weintraub, Sandra
Bigio, Eileen H.
Klein, William L.
Geula, Changiz
[J]. BRAIN, 2015, 138 : 1722 - 1737
[27] At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases
Barnado, April
Crofford, Leslie J.
Oates, Jim C.
[J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2016, 99 (02) : 265 - 278
[28] Dietary and lifestyle guidelines for the prevention of Alzheimer's disease
Barnard, Neal D.
Bush, Ashley I.
Ceccarelli, Antonia
Cooper, James
de Jager, Celeste A.
Erickson, Kirk I.
Fraser, Gary
Kesler, Shelli
Levin, Susan M.
Lucey, Brendan
Morris, Martha Clare
Squitti, Rosanna
[J]. NEUROBIOLOGY OF AGING, 2014, 35 : S74 - S78
[29] Neurogenic Subventricular Zone Stem/Progenitor Cells Are Notch1-Dependent in Their Active But Not Quiescent State
Basak, Onur
Giachino, Claudio
Fiorini, Emma
MacDonald, H. Robson
Taylor, Verdon
[J]. JOURNAL OF NEUROSCIENCE, 2012, 32 (16) : 5654 - 5666
[30] Changes in Brain Function Occur Years before the Onset of Cognitive Impairment
Beason-Held, Lori L.
Goh, Joshua O.
An, Yang
Kraut, Michael A.
O'Brien, Richard J.
Ferrucci, Luigi
Resnick, Susan M.
[J]. JOURNAL OF NEUROSCIENCE, 2013, 33 (46) : 18008 - 18014

← 1 2 3 4 5 6 7 8 9 10 →